Results 261 to 270 of about 95,709 (300)
Some of the next articles are maybe not open access.

Amyotrophic lateral sclerosis (ALS)-dementia complex

2004
Abstract Dementia within the context of ALS is unusual, but in most cases it is the frontotemporal dementia (FTD) type. This case was even more unusual in that the dementia was a rapidly progressive aphasic variety and was the first example of this type described. Neuropathologic study at autopsy demonstrated widespread cortical gliosis,
openaire   +1 more source

Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation

Nature Reviews Drug Discovery, 2022
Richard J Mead   +2 more
exaly  

Pridopidine in Amyotrophic Lateral Sclerosis

JAMA
ImportanceAmyotrophic lateral sclerosis (ALS) is a fatal disease. The sigma-1 (σ1) receptor emerged as a target for intervention.ObjectiveTo determine the effects of pridopidine, a σ1-receptor agonist, in ALS.Design, Settings, and ParticipantsPridopidine was tested as a regimen of the HEALEY ALS Platform Trial, a phase 2/3, multicenter, randomized ...
Douglas Hayden   +202 more
openaire   +2 more sources

Amyotrophic lateral sclerosis

Lancet, The, 2022
Eva Feldman   +2 more
exaly  

[Symptomatic management in amyotrophic lateral sclerosis (ALS)].

Praxis, 2006
Although disease-specific treatment of amyotrophic lateral sclerosis is still unsatisfactory, a number of advances have been made in the symptomatic therapy of ALS patients within the last decade. Current data suggest that active and aggressive multidisciplinary management of ALS patients improve their quality of life and prolong their survival ...
A, Czaplinski   +4 more
openaire   +1 more source

Amyotrophic lateral sclerosis

Nature Reviews Disease Primers, 2017
Orla Hardiman   +2 more
exaly   +2 more sources

Amyotrophic Lateral Sclerosis (ALS)

2009
J.M. Bhatt, H. Mitsumoto
openaire   +1 more source

Home - About - Disclaimer - Privacy